GlassScriptPhysician profile
Lori E Eduartez
NPI 1578990743
$1,770.69
in general payments reported to CMS, 2019-2025
25 companies · $638 in 2025
The $638 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $159 · 2023: $354 · 2024: $358 · 2025: $638.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,350.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $233.87 | 2022-2025 | Watchman Flx, Varithena Administration Pack, General - Therapies |
| Amgen INC. | $196.17 | 2021-2025 | Repatha, Repatha |
| Tactile Systems Technology INC | $192.66 | 2021-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Heartflow, INC. | $168.71 | 2024-2025 | |
| Novo Nordisk INC | $137.26 | 2021-2025 | Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $128.34 | 2023-2024 | Arexvy, Shingrix |
| Lilly USA, LLC | $113.32 | 2022-2025 | Mounjaro, Zepbound |
| Novartis Pharmaceuticals Corporation | $108.71 | 2023-2025 | |
| Cvrx, INC. | $61.29 | 2024-2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $51.00 | 2025 | Nexletol |
| Janssen Pharmaceuticals, INC | $49.85 | 2021-2022 | |
| Exact Sciences Corporation | $45.46 | 2024-2025 | Cologuard Collection Kit |
| Cashflow Solutions, LLC | $44.65 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Medtronic, INC. | $30.00 | 2024 | Venaseal |
| Abbott Laboratories | $25.07 | 2023 | Proclaim |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $22.69 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.18 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.22 | 2025 | Airsupra |
| Eisai INC. | $19.42 | 2025 | |
| Cleerly, INC. | $18.80 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Scpharmaceuticals INC. | $18.44 | 2023 | |
| Irhythm Technologies, INC. | $17.85 | 2024 | Zio Monitor, Zio Xt Patch |
| Abbvie INC. | $15.58 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.15 | 2021 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Eduartez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.